[Corrigendum] High glucose and high insulin conditions promote MCF‑7 cell proliferation and invasion by upregulating IRS1 and activating the Ras/Raf/ERK pathway.

breast cancer insulin receptor substrate 1 invasion proliferation type 2 diabetes mellitus

Journal

Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 22 05 2016
accepted: 04 04 2017
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 25 2 2023
Statut: ppublish

Résumé

Subsequently to the publication of this paper, an interested reader drew to the authors' attention that, in the wound‑healing assays portrayed in Fig. 2A on p. 6692, in the 0 h row, the 'NG + LI' and 'HG + HI' panels contained overlapping data, such that they appeared to have been derived from the same original source. After having examined their original data, the authors have realized that this figure was inadvertently assembled incorrectly. The corrected version of Fig. 2. showing the correct data for the 'HG + HI' panel, is shown on the next page. Note that this error did not significantly affect the results or the conclusions reported in this paper, and all the authors agree with the publication of this Corrigendum. Furthermore, the authors apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 6690‑6696, 2017; DOI: 10.3892/mmr.2017.7420].

Identifiants

pubmed: 36825576
doi: 10.3892/mmr.2023.12967
pii: 80
pmc: PMC10018242
doi:
pii:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumFor

Auteurs

Mei-Lin Wei (ML)

Department of Endocrinology and Metabolism, The Third Hospital of Nanchang, Nanchang Key Laboratory of Diabetes, Nanchang, Jiangxi 330009, P.R. China.

Peng Duan (P)

Department of Endocrinology and Metabolism, The Third Hospital of Nanchang, Nanchang Key Laboratory of Diabetes, Nanchang, Jiangxi 330009, P.R. China.

Zhi-Ming Wang (ZM)

Department of Endocrinology and Metabolism, The Third Hospital of Nanchang, Nanchang Key Laboratory of Diabetes, Nanchang, Jiangxi 330009, P.R. China.

Miao Ding (M)

Department of Endocrinology and Metabolism, The Third Hospital of Nanchang, Nanchang Key Laboratory of Diabetes, Nanchang, Jiangxi 330009, P.R. China.

Ping Tu (P)

Department of Endocrinology and Metabolism, The Third Hospital of Nanchang, Nanchang Key Laboratory of Diabetes, Nanchang, Jiangxi 330009, P.R. China.

Classifications MeSH